Lapatinib
CAS 231277-92-2 1 API supplierSmall Molecule
Overview
Lapatinib is a small molecule tyrosine kinase inhibitor used in the treatment of HER2-positive breast cancer. It works by inhibiting the epidermal growth factor receptor (EGFR) and HER2/neu receptor pathways, which are involved in tumor cell proliferation.
API suppliers (1)
Suppliers of Lapatinib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Where these suppliers are
China1
- Sichuan Xieli Pharmaceutical Co LtdChina
Therapeutic areas
OncologyBreast CancerHER2-positive Breast Cancer
Verified Supplier Partner
Do you supply Lapatinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.